杭州安杰思医学科技股份有限公司2026年第一次临时股东会决议公告

Group 1 - The first extraordinary general meeting of shareholders for 2026 was held on January 26, 2026, at the company's office in Hangzhou [2][3] - The total share capital as of the meeting's registration date was 81,122,079 shares, with 20,475 shares in the company's repurchase account not entitled to voting rights [2] - The meeting was convened by the board of directors and chaired by Chairman Zhang Cheng, utilizing a combination of on-site and online voting methods [3][4] Group 2 - Two ordinary resolutions were passed during the meeting: one regarding capital increase to a controlling subsidiary and another concerning providing guarantees for the controlling subsidiary [5][6] - The resolutions were approved by more than half of the voting rights held by shareholders present at the meeting, with separate counting for minority investors on the first resolution [6] - Related shareholders abstained from voting on the first resolution to avoid conflicts of interest [6] Group 3 - The meeting was witnessed by Beijing Deheng (Hangzhou) Law Firm, with lawyers Feng Lin and Yang Yang confirming that the meeting's procedures and resolutions complied with relevant laws and regulations [7]